Pinnacle Associates’s CollPlant Biotechnologies CLGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $690K | Buy |
507,193
+18,000
| +4% | +$24.5K | 0.01% | 570 |
|
|
2025
Q1 | $1.26M | Sell |
489,193
-500
| -0.1% | -$1.29K | 0.02% | 453 |
|
|
2024
Q4 | $1.76M | Buy |
489,693
+21,584
| +5% | +$77.7K | 0.02% | 390 |
|
|
2024
Q3 | $2.99M | Sell |
468,109
-96,251
| -17% | -$615K | 0.05% | 297 |
|
|
2024
Q2 | $2.8M | Buy |
564,360
+33,905
| +6% | +$169K | 0.04% | 314 |
|
|
2024
Q1 | $2.84M | Buy |
530,455
+62,346
| +13% | +$334K | 0.04% | 321 |
|
|
2023
Q4 | $2.99M | Sell |
468,109
-10,200
| -2% | -$65.2K | 0.05% | 300 |
|
|
2023
Q3 | $2.66M | Sell |
478,309
-6,344
| -1% | -$35.3K | 0.05% | 311 |
|
|
2023
Q2 | $3.95M | Buy |
+484,653
| New | +$3.95M | 0.07% | 258 |
|